ZOLL Medical Corporation, a subsidiary of the Asahi Kasei Group, specializes in the development and marketing of medical devices and software solutions designed to enhance emergency care and improve the efficiency of clinical operations. The company’s product range includes defibrillators, patient monitors, CPR feedback systems, data management software, fluid resuscitation tools, and therapeutic temperature management devices. ZOLL's technologies support a wide array of users, including clinicians, emergency medical services (EMS), fire professionals, and lay rescuers, enabling them to effectively treat patients requiring resuscitation and acute critical care. By providing comprehensive solutions, ZOLL aims to advance the standards of emergency medical services and ultimately save lives.
Vyaire Medical is a global medical device company specializing in respiratory diagnostics, ventilation, and anesthesia delivery and patient monitoring. With over fifty years of experience, it is recognized as a leader in these markets and is the largest pure-play company dedicated to breathing support. Vyaire collaborates with healthcare providers and hospitals to enhance patient outcomes and create value in their partnerships. The company offers a range of innovative products and services designed to improve access to clinical data and provide differentiated support. By focusing on the needs of healthcare professionals, Vyaire Medical aims to improve the lives of patients through its advanced technologies and dedicated service, making it a trusted choice in the medical device industry.
Itamar Medical
Acquisition in 2021
Itamar Medical Ltd. is a medical device company based in Caesarea, Israel, specializing in the research, development, marketing, and sale of non-invasive medical devices for the cardiology market. Founded in 1997, the company utilizes its proprietary Peripheral Arterial Tone (PAT) signal technology to create devices that assess various cardiovascular and respiratory conditions. Its flagship products include the WatchPAT device, which facilitates home testing for sleep disorders such as obstructive sleep apnea, and the EndoPAT device, which is designed to diagnose endothelial dysfunction and evaluate the risk of coronary artery disease. Itamar Medical operates across multiple regions, including the United States, Europe, Canada, Japan, and the Asia Pacific. The company also collaborates with SoClean Inc. to enhance the distribution of its home sleep apnea test and digital health services through direct-to-consumer channels.
Respicardia
Acquisition in 2021
Respicardia, Inc. is focused on enhancing the health of heart failure patients through the development and manufacturing of implantable stimulation therapy solutions. The company's primary product, the remedē System, is an implantable device designed to restore natural breathing patterns during sleep in patients with central sleep apnea. This device utilizes transvenous neurostimulation technology to stimulate the phrenic nerve, thereby improving respiratory rhythm management and overall cardiovascular health. Founded in 2006 and based in Minnetonka, Minnesota, Respicardia aims to improve patient outcomes through innovative therapies that address the critical needs of those suffering from respiratory and cardiovascular diseases. The company has also established a strategic partnership with Sorin Group to further its mission.
RoundTrip
Venture Round in 2020
RoundTrip, Inc. operates a digital marketplace that facilitates non-emergency medical transportation by connecting patients with a network of ride providers. Founded in 2014 and based in Philadelphia, Pennsylvania, the company offers a user-friendly software platform that allows healthcare organizations and transportation companies to schedule, dispatch, and monitor patient rides. RoundTrip serves hospitals and health plans in ten states, aiming to improve care coordination and reduce patient no-shows. The platform provides access to various transportation options, including medical cars, wheelchair vans, and stretcher vehicles. RoundTrip has established strategic partnerships with notable healthcare organizations, enhancing its service offerings. The team behind RoundTrip consists of professionals with experience as paramedics and in healthcare management, which informs their approach to addressing the challenges in medical transportation.
Impulse Dynamics
Series D in 2019
Impulse Dynamics N.V. is a medical device company focused on developing electrical therapies for chronic heart failure, operating primarily in the United States and Europe. The company's key innovation is its cardiac contractility modulation (CCM) therapy, which utilizes non-excitatory electrical impulses delivered to the heart muscles. This therapy aims to enhance cardiac strength and improve blood flow, offering a minimally invasive treatment option for patients with limited alternatives. Impulse Dynamics conducts clinical trials to assess the safety and efficacy of its therapies and collaborates with universities and hospitals for research initiatives. Founded in 1996 and headquartered in Willemstad, Curacao, the company also maintains offices in New York and Hong Kong, alongside product development centers in New Jersey and Israel.
Mobilize
Acquisition in 2019
Mobilize is a privately held company that focuses on emergency technology, specifically through its Mobilize Rescue Systems app and related rescue kits. The company's offerings are designed to assist individuals in assessing and managing various medical emergencies. Mobilize's technology provides clear instructions and essential supplies for addressing situations such as severe bleeding, cardiac arrest, seizures, choking, chest trauma, hypothermia, and burns. By equipping bystanders with the necessary resources, Mobilize aims to empower them to effectively respond to medical crises and potentially save lives.
TherOx
Acquisition in 2019
TherOx, Inc. is a medical device company based in Irvine, California, focused on enhancing the treatment of heart attack patients through its innovative dissolved oxygen delivery systems. The company's primary offering, SuperSaturated Oxygen Therapy (SSO2), utilizes the TherOx DownStream system, which combines a mobile device with a cartridge to create superoxygenated blood. This blood is then delivered directly to the coronary arteries to improve blood flow and promote healing of damaged heart tissue. Founded in 1994, TherOx has conducted extensive research through benchtop studies, animal studies, and clinical trials to validate its technology. In addition to heart attacks, the company is exploring the use of SSO2 therapy in other medical fields, including stroke, oncology, and wound care. TherOx holds 20 issued patents, with further applications pending, reflecting its commitment to advancing medical treatment standards. As of June 2019, TherOx operates as a subsidiary of ZOLL Medical Corporation.
Cardiac Science
Acquisition in 2019
Cardiac Science Corporation specializes in the design, manufacture, and marketing of automated external defibrillators (AEDs) aimed at addressing sudden cardiac arrest (SCA) in various public and private settings. Their product line includes the Powerheart G5 and Powerheart G3 Plus AEDs, which are designed for ease of use in critical situations. The company also offers training devices, such as the Powerheart G5 Trainer and Powerheart G3 Trainer, to prepare users for real-life rescue scenarios. In addition to AEDs, Cardiac Science provides a range of accessories, including wall cabinets, signage, and maintenance kits, alongside services like training and technical support. The company caters to a diverse clientele, including corporations, schools, healthcare facilities, and emergency services. With a global presence, Cardiac Science aims to ensure the availability and simplicity of AEDs to facilitate timely defibrillation and improve survival rates from cardiac incidents. Headquartered in Waukesha, Wisconsin, it operates multiple locations internationally and is a subsidiary of ZOLL Medical Corporation.
Golden Hour
Acquisition in 2019
Golden Hour Data Systems, Inc. specializes in providing integrated solutions for the emergency medical transportation industry, focusing on both air and ground medical transport. The company offers a comprehensive platform that combines dispatch, clinical charting, analytics, and billing services into a single solution, enhancing operational efficiency and maximizing revenue for its clients. Golden Hour Live serves as an Internet-based solution that integrates various functions, including transfer center operations, communications, and flight following, while also ensuring compliance and quality assurance. Additionally, the company provides billing and collections services, along with practice management offerings such as program assessments, training, strategic planning, and data analysis. Recognized as a leader in billing and reimbursement within the air medical transportation sector, Golden Hour supports over 80% of the market through its patented technologies and revenue cycle management services. Founded in 1997 and based in San Diego, California, Golden Hour operates as a subsidiary of ZOLL Medical Corporation.
Payor Logic
Acquisition in 2019
Payor Logic is a company that focuses on providing specialized accounts receivable (A/R) software solutions tailored for the healthcare sector. With expertise in various areas including Emergency Medical Services, laboratories, long-term care facilities, physician groups, billing companies, accountable care organizations, and hospitals, Payor Logic aims to enhance financial processes in healthcare. The company offers a suite of services that includes insurance discovery, patient demographic verification, payment likelihood prediction, and prior authorization and eligibility verification. By delivering actionable data and streamlined workflows, Payor Logic helps healthcare providers ensure accurate patient information, accelerate reimbursement processes, and simplify management of self-pay accounts.
TherOx
Debt Financing in 2018
TherOx, Inc. is a medical device company based in Irvine, California, focused on enhancing the treatment of heart attack patients through its innovative dissolved oxygen delivery systems. The company's primary offering, SuperSaturated Oxygen Therapy (SSO2), utilizes the TherOx DownStream system, which combines a mobile device with a cartridge to create superoxygenated blood. This blood is then delivered directly to the coronary arteries to improve blood flow and promote healing of damaged heart tissue. Founded in 1994, TherOx has conducted extensive research through benchtop studies, animal studies, and clinical trials to validate its technology. In addition to heart attacks, the company is exploring the use of SSO2 therapy in other medical fields, including stroke, oncology, and wound care. TherOx holds 20 issued patents, with further applications pending, reflecting its commitment to advancing medical treatment standards. As of June 2019, TherOx operates as a subsidiary of ZOLL Medical Corporation.
Respicardia
Venture Round in 2017
Respicardia, Inc. is focused on enhancing the health of heart failure patients through the development and manufacturing of implantable stimulation therapy solutions. The company's primary product, the remedē System, is an implantable device designed to restore natural breathing patterns during sleep in patients with central sleep apnea. This device utilizes transvenous neurostimulation technology to stimulate the phrenic nerve, thereby improving respiratory rhythm management and overall cardiovascular health. Founded in 2006 and based in Minnetonka, Minnesota, Respicardia aims to improve patient outcomes through innovative therapies that address the critical needs of those suffering from respiratory and cardiovascular diseases. The company has also established a strategic partnership with Sorin Group to further its mission.
Kyma Medical Technologies
Acquisition in 2015
Kyma Medical Technologies is an early-stage medical device company focused on cardiovascular diagnostics. Founded in March 2008, the company is developing a dual modality non-invasive diagnostic system aimed at detecting in-stent restenosis. In addition to its work in cardiovascular diagnostics, Kyma is also creating a remote patient monitoring solution specifically for patients with congestive heart failure. This solution includes a small patch that adheres to the patient's torso, wirelessly transmitting health data to a remote center via a gateway device such as a smartphone.
Advanced Circulatory System
Acquisition in 2014
Advanced Circulatory Systems specializes in the development and marketing of intrathoracic pressure regulation products designed to enhance circulation and restore life in patients facing cardiac arrest, low blood pressure, and head injuries. The company offers non-invasive technologies that improve blood flow by utilizing the body’s physical mechanisms, without relying on pharmaceuticals or mechanical devices. Its products cater to military, emergency medical services, and hospital markets, and are distributed in over 25 countries globally. By focusing on circulatory enhancement, Advanced Circulatory Systems aims to protect vital organs and improve patient outcomes during critical medical emergencies.
Infusion Dynamics
Acquisition in 2014
Infusion Dynamics specializes in the design and manufacture of innovative portable medical devices intended for both pre-hospital and hospital settings. One of its key products is the Power Infuser, a miniature infusion pump designed specifically for intravenous fluid resuscitation. The company's devices are primarily utilized by the U.S. Military, demonstrating their commitment to meeting the needs of critical care in various environments.
CoAxia
Acquisition in 2013
CoAxia is a medical device company located in Minneapolis, Minnesota, specializing in solutions for cerebral ischemia. The company develops innovative devices aimed at controlling blood flow, specifically the NeuroFlo and FloControl systems. These devices are designed to redirect blood flow to the brain, thereby helping to reduce the risk of stroke and heart attack in patients experiencing conditions such as vasospasm and heart blockage. Through its research and development efforts, CoAxia focuses on improving treatment outcomes for individuals suffering from these serious medical conditions.
Alsius
Acquisition in 2009
Alsius is a medical device company based in California, established in 1991, that specializes in the development and distribution of intravascular temperature management products. The company focuses on creating advanced therapies for critically ill patients, offering solutions that enable precise temperature control in critical care settings such as intensive care units, emergency departments, and surgical environments. Alsius's product portfolio includes a variety of medical devices and consumables, addressing needs in bone regeneration, neuro-monitoring, and temperature management, among others. By providing reliable and innovative products, Alsius aims to enhance patient care and improve outcomes in hospital settings.
Radiant Medical
Acquisition in 2007
Radiant Medical is a private medical device company based in Redwood City, California, established in 1999. The company specializes in endovascular temperature therapy, focusing on the treatment of heart, brain, and kidney disorders. Its primary product is a single-use central venous heat exchange balloon catheter, which works in conjunction with a heat exchange cassette, a microprocessor-driven controller, and an integrated temperature sensor. This innovative system allows for the safe and rapid reduction, maintenance, and warming of a patient’s core body temperature, enhancing treatment efficacy in critical care settings.
Pinpoint Technologies
Acquisition in 1999
Pinpoint Technologies, founded by David Cohen in 1993 and based in Boulder, Colorado, specializes in developing software solutions for the emergency medical services sector. The company's primary product, RightCAD, is a comprehensive computer-aided dispatch and billing system that integrates various functionalities into a single platform. This software enables users to manage dispatching, claim verification, automatic pricing, and batch posting of credits, all utilizing a common database. By offering these streamlined services, Pinpoint Technologies aims to enhance operational efficiency within the emergency medical services market.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.